Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Learning Disabilities01:25

Learning Disabilities

272
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
272
Classification of Illness01:17

Classification of Illness

8.0K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Late-onset multiple sclerosis is associated with relapse-independent disability accrual: a propensity score-weighted recurrent-event study.

Journal of neurology·2026
Same author

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

A Comparative Study of QSPR Methods on a Unique Multitask PAMPA Data Set.

Journal of chemical information and modeling·2026
Same author

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Journal of neurology·2026

Related Experiment Video

Updated: Sep 14, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K

Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine

Ashkan Pirmani1,2,3,4, Edward De Brouwer1, Ádám Arany1

  • 1STADIUS, ESAT, KU Leuven, Leuven, Belgium.

NPJ Digital Medicine
|July 24, 2025
PubMed
Summary

Personalized federated learning improves prediction of multiple sclerosis disability progression. This privacy-preserving approach adapts models to local data, outperforming standard methods for earlier patient intervention.

More Related Videos

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.2K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Related Experiment Videos

Last Updated: Sep 14, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.2K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Area of Science:

  • Artificial Intelligence
  • Computational Neuroscience
  • Clinical Informatics

Background:

  • Predicting multiple sclerosis (MS) disability progression is crucial for treatment but remains challenging.
  • Existing federated learning (FL) methods face limitations due to data heterogeneity across institutions.
  • Privacy-aware collaborative modeling is essential for leveraging multi-center patient data.

Purpose of the Study:

  • To systematically evaluate personalized federated learning (PFL) for predicting 2-year MS disability progression.
  • To assess the efficacy of PFL in overcoming data heterogeneity in multi-center real-world MS datasets.
  • To compare PFL strategies against conventional FL and centralized approaches.

Main Methods:

  • Utilized multi-center real-world data from over 26,000 multiple sclerosis patients.
  • Implemented and evaluated two PFL strategies: AdaptiveDualBranchNet and personalized fine-tuning.
  • Benchmarked PFL performance against baseline FL, centralized models, and client-specific models.

Main Results:

  • Personalized federated learning significantly improved prediction performance compared to baseline FL.
  • Personalized FedProx and FedAVG achieved high predictive accuracy (ROC-AUC ~0.84).
  • PFL methods effectively addressed data heterogeneity challenges while maintaining privacy.

Conclusions:

  • Personalization is critical for developing scalable, privacy-aware clinical prediction models in MS.
  • PFL demonstrates significant potential for improving early intervention strategies in multiple sclerosis.
  • This approach can be extended to other complex neurological disorders and clinical prediction tasks.